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Abstract 
 
Hypoxic stress occurs when a cell is exposed to below normal (2-20µM) oxygen 
concentrations. To survive, the cell must activate necessary genes that regulate hypoxic cell 
function and metabolism. Hypoxic genes in mammalian cells are activated by transcription 
factors known as Hypoxic Inducible Factors (HIFs). HIF is regulated by hypoxic stabilization of 
the HIF-α subunit; however the mechanism of HIF-α stabilization has not been unequivocally 
determined. Under hypoxic conditions, evidence suggests that the mitochondrial respiratory 
chain is required for HIF-α stabilization. The electron transport chain produces superoxide and 
nitric oxide, species that may serve as an intracellular signal. While the current body of literature 
supports a role of superoxide in hypoxic HIF-α stabilization, the goal of this study was to 
determine the role of mitochondrial nitric oxide involvement in mediating the regulation of HIF-
α. Nitric oxide and superoxide readily react to form peroxynitrite, a potent nitrating agent, which 
adds nitro groups to tyrosines and carbonylates proteins. Here, I find that following a shift to 1% 
oxygen for three hours, human embryonic kidney cells, HEK293, exhibit a nitric oxide 
dependent increase in tyrosine nitration as well as protein carbonylation. Furthermore, 
preliminary studies demonstrate that cytochrome c oxidase produces the nitric oxide. These 
findings suggest a possible role of protein tyrosine nitration and/or carbonylation as a signaling 
mechanism during hypoxic stress. 
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Introduction 
 
Mitochondria and Oxygen 
Many eucaryotic organisms require the presence of mitochondria to survive. If 
mitochondria malfunction, cells may die or experience a variety of disorders such as: metabolic 
diseases, neuropathies, and myopathies1-3. A few common disorders include Huntington’s 
disease, Multiple Sclerosis, Alzheimer’s disease and Parkinson’s disease, all of which the 
mitochondria partly contribute to the pathology of the disease3,4. In high-energy consuming 
tissues, like muscles and neurons, an array of physiological disorders arises from malfunctioning 
mitochondria. Clearly, the mitochondria play an essential role in the well being and health of an 
individual.  
Mitochondria are most recognized for their role in the generation of cellular 
energy through oxidative phosphorylation, the synthesis of ATP that provides most of the energy 
for cellular process. One crucial component for oxidative phosphorylation is the presence of the 
electron transport chain in the inner mitochondrial membrane. The electron transport chain 
removes the electrons carried by NADH and FADH2, and in doing so regenerates NAD+, FAD, 
and the redox balance for glucose catabolism to proceed. NADH transfers two electrons to 
complex I in the electron transport chain, while FADH2 deposits two electrons at complex II. 
While the electrons continue to pass from electron carrier to carrier along the chain, complexes I, 
III and IV selectively pump protons from the mitochondrial matrix to the inner membrane space. 
This transport in protons creates an electrochemical gradient across the inner membrane, driving 
ATP synthesis. Without the electron transport chain to stimulate the proton motive force that 
generates ATP for the cell, much of the cellular energy is lost.  
C a r l s o n  | 3 
A terminal electron acceptor must be present to accept the electrons from complex 
IV, allowing more electrons to flow down the electron transport chain. In some organisms, the 
terminal electron acceptors for the respiratory chains include sulfate, nitrate, iron (III), and 
elemental sulfur. For example, the bacterium Pseudomonads, reduces nitrate, NO3- to dinitrogen, 
N2, through multiple electron transfers in a process of denitrification5. However, this process 
occurs along multiple steps where nitrate reductase catalyzes the reduction of nitrate to nitrite, 
which gets passed onto nitrite reductase. Nitrite reductase, cytochrome c,d1, converts nitrite to 
nitric oxide via a nitrosyl transfer mechanism6. The nitric oxide undergoes two more reduction 
reactions, eventually forming dinitrogen. The reduction of these compounds maintains the redox 
balance in the bacterial cell, allowing respiration to continue. 
In eucaryotes, as obligate aerobes, this terminal electron acceptor is oxygen. 
Complex IV, cytochrome c oxidase, transfers a total of four electrons and four protons to oxygen 
to produce two water molecules. When oxygen concentration decreases, the availability of 
oxygen for respiration also becomes limited resulting in a transient decrease in ATP production. 
Hypoxia is defined between 2 and 20 µM oxygen concentrations, and anoxia occurs at less than 
2 µM oxygen, the concentration at which oxygen acts as the rate limiting substrate for 
respiration7. During hypoxia and anoxia, ATP generation shifts more towards glycolysis rather 
than from oxidative phosphorylation due to the lack of oxygen as a terminal electron chain 
acceptor. Glycolysis yields only 2 ATP molecules instead of the 36-38 ATP molecules generated 
under aerobic conditions, an 18 fold difference in ATP production. It has recently been 
discovered that under hypoxic conditions eucaryotic cells can utilize nitrite as the terminal 
electron acceptor, generating nitric oxide, and thus maintain proton motive force for the 
generation of mitochondrial ATP even under extreme anoxic conditions8.  
C a r l s o n  | 4 
Under prolonged hypoxia, the cells optimize the efficiency of the electron 
transport chain in order to generate the most electrochemical potential per oxygen molecule 
available by switching out a subunit in the terminal electron acceptor in the respiratory chain. In 
yeast, subunit V of cytochrome c oxidase has two isoforms, Va and Vb that are nuclear encoded 
by COX-5a and COX-5b genes. COX-5b is a hypoxic gene and up-regulated under lowered 
oxygen levels, while its counterpart, COX-5a becomes down-regulated; thus the hypoxic cell has 
lowered expression of Va and higher levels of Vb9. Vb cytochrome c oxidase isoforms have a 
faster turnover of intramolecular electron transfer than the Va isoform10. This property makes Vb 
more efficient, allowing it to quickly reduce the remaining oxygen to H2O, or nitrite to nitric 
oxide, NO., so that the mitochondria can continue to generate ATP for the cell.  
In mammalian cells, nuclear encoded subunit 4 contains two isoforms that 
correspond to subunit V in yeast. Cytochrome c oxidase isoforms 4-1 is expressed under aerobic 
conditions, but when the oxygen levels drop, 4-2 expression increases in the cell11,12. While ATP 
binds allosterically to subunit 4, decreasing cytochrome c oxidase effectiveness, the presence of 
4-2 reduces the effect of ATP regulation, allowing the enzyme to operate optimally under 
hypoxia13,14. The regulation of cytochrome c oxidase by the hypoxic isoform of subunit 4 results 
in a more efficient enzyme, allowing the complex to reduce oxygen under conditions that would 
normally repress oxygen consumption. With oxygen consumption, and the electrons flowing 
through the respiratory chain, the mitochondria maintain the electrochemical gradient between 
the mitochondrial matrix and inner membrane and allow the continued production of ATP under 
hypoxic stress.  
However, cells must sense the environmental shift in oxygen concentrations in 
order to respond appropriately to maintain balance of the cell’s energy consumption and 
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production. The switch from cytochrome c oxidase subunit 4-1 to 4-2 begins with the 
stabilization of Hypoxia Inducible Factor-alpha (HIF-α), part of a dimeric HIF-α/β (HIF) 
transcription factor. While HIF regulates both isoforms of cytochrome c oxidase subunit 4, HIF 
also plays a major role in oxygen sensitive transcription that regulates the hypoxic response in 
mammalian cells. COX 4-2 contains a hypoxia response element, where HIF binds and facilitates 
4-2 transcription and expression12. Moreover, cytochrome c oxidase subunit 4-1 has been found 
to be down-regulated by a mitochondrial protease LON, whose expression is directly regulated 
by HIF12. In this manner, HIF contributes to the expression of 4-2 rather than isoform 4-1 during 
hypoxia.  
 
HIF as the master hypoxia regulator 
Not only does HIF regulate mitochondrial cytochrome c oxidase subunits, HIF 
also regulates the expression of many other genes necessary for hypoxic cell survival. HIF 
activates the transcription of genes such as VEGF, vascular endothelial growth factor, and 
glycolytic enzymes15-17. By activating the transcription of these genes, HIF initiates a response to 
hypoxia to maintain cellular energy consumption and production. The regulation of these 
enzymes in addition to cytochrome c oxidase contributes to HIF’s role as master regulator of the 
hypoxic response.  
In order for HIF to regulate the transcription of all these hypoxic genes, it must be 
regulated in an oxygen sensitive manner as well. HIF is composed of two subunits, α and β; both 
subunits must come together for translocation into the nucleus, where HIF performs its duty as a 
transcription factor. If a functioning dimer were to exist at all moments, the hypoxic response 
would become activated under aerobic conditions. While both subunits are constitutively 
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transcribed and translated, the protein stability of the α subunit is sensitive to oxygen 
concentrations18-20. HIF-α, is post translationally modified and subsequently degraded under 
aerobic conditions. Only under hypoxia does HIF-α protein expression become stabilized, 
allowing it to dimerize with HIF-β to activate the transcription of hypoxic response genes.  
The mechanism of HIF-α degradation under aerobic conditions has been 
extensively studied. First, Proline-4-hydroxylase hydroxylates two exterior proline residues, 
Pro402 and Pro564 on HIF-α, which drives HIF-α towards proteosomal degradation21-23. Without 
these key proline residues, HIF-α accumulates under aerobic conditions24. Additionally, HIF-α is 
hydroxylated at Asn851 which further disables HIF-α function by preventing its interaction with a 
cofactor, p30025. Following hydroxylation, HIF-α becomes ubiquinated and forms a complex 
with the von-Hippel Lindau Tumor Suppressor protein26. This complex serves as a recognition 
site for the E3 ubiquitin-protein ligase complex that cleaves HIF-α in the proteosome. In essence, 
under aerobic conditions, HIF-α is readily hydroxylated and targeted for proteosomal 
degradation.  
 
Hypoxic HIF-α stabilization 
When exposed to hypoxia, HIF-α stabilizes, dimerizes with HIF-β, translocates to 
the nucleus, and functions as a transcription factor to activate the expression of hypoxic genes. In 
wild-type cells, HIF-α begins to stabilize below 5% oxygen concentration, 50 µM, with peak 
stabilization at 0.5% O2, 5 µM7,19. Conversely, in ρ0 cells, or in respiratory inhibited cells, HIF-α 
does not become stable until near anoxic conditions where the oxygen availability limits the 
PHD hydroxylation activity27,28. Because inhibition of the respiratory chain suppresses hypoxic 
stabilization of HIF, it has been concluded that the respiratory chain plays a role in oxygen 
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sensing and the hypoxic stabilization of HIF. There are two schools of thought as to how this 
might occur. 
The oxygen sink model details that the lack of oxygen as a substrate for the 
proline hydroxylases under lower oxygen levels prevents the hydroxylation of HIF-α resulting in 
its stabilization. An argument against the oxygen sink model is that HIF-α is stable up to 5% 
oxygen19. Under these hypoxic conditions, oxygen is still present to serve as a substrate for the 
proline hydroxylases. However, this theory rebukes that the cytochrome c oxidase’s low Km for 
oxygen, at 95 µM acts as an oxygen sink in the cell29. Thus, during hypoxia, cytochrome c 
oxidase sequesters the cellular oxygen and leaves proline hydroxylases without a substrate to 
modify HIF-α. Proline hydroxylase’s Km for oxygen of lies between 230-250 µM, much higher 
than the Km of cytochrome c oxidase, resulting with proline hydroxylase activity dependent on 
the presence of aerobic concentrations of oxygen30. This theory solely looks at the availability of 
oxygen to serve as a substrate for proline hydroxylase, and its lack thereof leading to HIF-α 
stabilization.  
The ROS theory of HIF-α stabilization argues that the mitochondria, while 
important for the generation of cellular energy, may also play an important role in intracellular 
signaling for the hypoxic stabilization of HIF-α. The mitochondrial electron transport chain 
possesses the ability to produce reactive oxygen and nitrogen species that increases under 
hypoxic conditions8,27,31-33. The ROS theory of HIF-α stabilization claims that reactive species 
generated by the mitochondrial respiratory chain under hypoxic stress are necessary for the 
hypoxic stabilization of HIF-α.  Additionally, this theory suggests that the mitochondrially 
produced reactive species participate in an intracellular oxygen sensing mechanism, instigating a 
cellular response to hypoxia. 
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Reactive species and HIF-α Stabilization 
Reactive species and free radicals such as superoxide, O2.-, peroxynitrite, ONOO-, 
and nitric oxide, NO., are highly unstable molecules that will readily react with other 
compounds. Traditionally thought of as damaging and detrimental to cells, these reactive 
molecules have been linked to several diseases including: Alzheimer’s disease, Parkinson’s 
Disease, and Multiple Sclerosis4,34. However, these reactive species have also been shown to act 
as signaling molecules in other diseases such as Leber Hereditary Optic Neuropathy where 
decreased levels of O2.- contribute to the pathology of the disease, suggesting a role for ROS in 
intracellular signaling1. Science magazine named NO. the molecule of the year in 1992 for its 
diverse use as a signaling molecule in the body35. By acting as part of a signaling pathway, ROS 
and RNS may contribute to the hypoxic stabilization of HIF-α.   
Scheme 1Mitochondrial Respiratory Chain Generation of Free Radicals. As electrons are passed from 
carrier to carrier, complex I and III can prematurely ‘leak’ electrons to oxygen, a one electron reduction. 
Complex IV, cytochrome c oxidase, can utilize nitrite as an alternative electron acceptor, producing nitric 
oxide.  
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While some enzymes in the cell function to produce ROS/RNS, like nitric oxide 
sythase, the mitochondrial respiratory chain also generates reactive oxygen species and free 
radicals. While nearly perfectly efficient in its conversion of reducing power to electrochemical 
work, the electron transport chain can ‘leak’ electrons, generating free radicals and reactive 
species, as shown in Scheme 1. At complex I and III of the electron transport chain, the escape of 
electrons reduce oxygen to the reactive superoxide, O2.- 27. Moreover, a functional complex III is 
necessary to observe HIF-α protein levels under hypoxia, suggesting an importance of 
superoxide formation in the process of stabilizing HIF-α27,36. The generation of superoxide 
occurs under aerobic and hypoxic conditions when there is an availability of oxygen, but not 
anoxia, where HIF-α stabilization is not complex III or superoxide dependent.  
Additionally, under hypoxic/anoxic conditions, complex IV, cytochrome c 
oxidase can utilize nitrite as an alternative electron acceptor. By reducing nitrite to NO., also 
shown in Scheme 1, cytochrome c oxidase contributes 
to the generation of free radicals in the cell8. Scheme 2 
demonstrates that under hypoxic and anoxic conditions, 
NO. production increases (A.), whereas O2.- generation 
decreases with hypoxia, disappearing when oxygen 
concentrations reach anoxic levels (B.). Furthermore, it 
has been demonstrated that the hypoxia-expressed 
subunit Vb in yeast has a higher capability to produce 
NO. than Va37. While cytochrome c oxidase is required 
for the induction of hypoxic genes, this requirement 
may not be to act as an oxygen sink38. NO. increases the 
Scheme 2 Free Radical Dependence on 
Oxygen Concentration (43). As oxygen 
concentration decreases, NO. concentration 
increases (A.).  O2.- is present under aerobic 
conditions, NO. present under anoxic 
conditions, and both species are present under 
hypoxic conditions, where they react to form 
ONOO- (B.). 
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cytochrome c oxidase’s Km for oxygen, lending to disrupt the oxygen sink theory; if cytochrome 
c oxidase has a higher Km for oxygen, it no longer acts as an oxygen sink, and oxygen becomes 
available for proline hydroxylases to modify HIF-α24,39. Instead cytochrome c oxidase may be 
required for its generation of NO., suggesting a role for the free radical molecule in hypoxic 
intracellular signaling.  
Nitric oxide has recently been 
implicated in the stabilization of HIF-α, where 
addition of NO. scavengers cause a concentration 
dependent reduction in hypoxic HIF-α levels (Figure 
1, unpublished data, Ball and Foster). Although both 
nitric oxide sythase and cytochrome c oxidase can 
generate the NO. required for HIF-α stabilization, 
nitric oxide sythase generated NO. accounts for only 
small portion of the total NO. production under 
hypoxic conditions, with the remainder coming from 
the reduction of nitrite to NO. 40.   
 
 
 
 
 
 
 
Figure 1 HIF-1 expression levels decrease  in 
response to NO. scavengers. HEK293 cells were 
shifted to 1% oxygen for three hours in high 
glucose DMEM media with 110 mg/L sodium 
pyruvate in a Biospherix Hypoxic Box. Active 
Motif nuclear extraction kit was used to produce 
a nuclear extract.  The nuclear extract was 
examined (A.) using Active Motif HIF-1 ELISA 
assay for active HIF-1 levels and  (B.) using 
SDS-Page followed by Western Blot of HIF-
1alpha (1:1000, BD Biosciences) and Histone 
H2B (1:30000, Cell Signaling) and quantified 
using the previously described method (70). 
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Protein Tyrosine Nitration and Carbonylation 
While the mechanism of ROS stabilization of hypoxic HIF-α is not fully 
understood, there are hypotheses as to how this might occur. ROS and RNS may serve as 
signaling ligands, binding to a receptor that induces the hypoxic stabilization of HIF-α. NO. is a 
known ligand, binding to iron hemes in guanyl cyclases and inferring a relaxing (vasodilator) 
effect in smooth muscle41. In addition to serving as ligands, reactive oxygen species also alter 
proteins via post translational modifications. Together, NO. and O2.- react to form peroxynitrite, 
ONOO-, another highly reactive species that can modify amino acid residues. Specifically, 
protein tyrosine nitration, the addition of NO2 to the 3 position of tyrosine’s aromatic ring, has 
been used as an indicator of ONOO- formation in a cell, detectable by immunochemical and 
spectrophotometric techniques42. ONOO- also mediates protein carbonylation, the oxidation of 
arginine, threonine, proline and lysine residues43,44.  
However, for protein nitration or carbonylation to participate in a signaling 
pathway, these post-translational modifications must be reversible, have specific targets, and 
alter protein function upon oxidation. Following a shift to hypoxia, there is a transient increase of 
protein carbonylation as well as protein tyrosine nitration in yeast, demonstrating that both 
nitration and carbonylation are reversible processes8,32. However, the specificity of protein 
carbonylation and nitration following hypoxia in a mammalian system, as well as the effect of 
these proteins on the stability of HIF-α has not been investigated. 
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The shape of this study was constructed with the understanding that NO. derived 
from complex IV is necessary for the stabilization of HIF-α, and that NO. reacts with O2.- to 
produce ONOO- which mediates protein nitration and carbonylation. The modified proteins may 
potentially initiate a signaling cascade leading to the stabilization of HIF-α. The goal of this 
study was to investigate the role of NO. in the formation of protein tyrosine nitration and protein 
carbonylation in order to hypothesize their role in hypoxic HIF-α stabilization. Mammalian cells 
were shifted to hypoxia and a nitric oxide dependent increase in protein nitration and 
carbonylation was observed. Furthermore, cytochrome c oxidase appears responsible for the 
production of the nitric oxide involved in the hypoxia dependent increase in nitration and 
carbonylation. 
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Materials and Methods 
 
Mammalian Cell Strains and Media 
The experiments were conducted using HEK293ft, Human Embryonic Kidney, 
for transfection cells, grown in a high glucose DMEM media (Invitrogen) supplemented with 
10% Fetal Bovine Serum, FBS and 1% Penicillin-Streptomycin. 
 
Growth Conditions and Hypoxic Shifts 
Cells grew at 37ºC and 5% CO2 and experiments performed when the cells 
reached 85-95% confluence. Two types of hypoxic shifts were performed: an anoxic ‘minishift’ 
and a hypoxic ‘maxishift.’  
Minishift – For the ‘minishifts,’ cells were shifted in a sealable chamber in which 
NO. and O2 electrodes could be placed. The chamber and electrodes were cleaned with 3% enzol 
for 5 minutes, and prepared by washing with dH2O. Adherent cells were trypsinized from the 
growth plates, washed in 1X PBS (80mM Na2HPO4, 20mM NaH2PO4, 1.0 M NaCl, pH 7.5) and 
resuspended in the assay buffer of low glucose DMEM media (Invitrogen), with a final volume 
of 3 mL. 800 µL was then removed from the chamber for the aerobic sample, and the chamber 
lid was closed. Anoxia was reached at 6 minutes when the O2 = 0%, starting the anoxic clock at 
t=0. At t=90 minutes and t=120 minutes, 600 µL was removed from the chamber. The samples 
removed from the chamber were centrifuged at 5,000 rpm for 5 min at 4ºC, and then the 
supernatant was removed. After washing the cell pellet with 1 mL of cold 1X PBS, the cells were 
centrifuged again at 5,000 rpm for 5 min at 4ºC. Pelleted cells were immediately lysed or stored 
at -20ºC.  
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Maxishift – For the hypoxic ‘maxishifts’, designated cells, 85-95% confluent, 
were placed in the Biospherix Proox C21 box, inside the incubator, with high glucose DMEM 
media (Invitrogen) supplemented with 10% FBS and 1% Penicillin – Streptomycin. The aerobic 
control was placed outside the Biospherix hypoxic box, inside the incubator, with the same high 
glucose DMEM (Invitrogen) and removed from the incubator at the same time that the hypoxic 
samples were removed. Experimental cell plates were supplemented to a final concentration 
with: 1 mM PTIO (4-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide) (Sigma –P5084) to 
scavenge NO., or 5 mM sodium azide (Sigma) to inhibit cytochrome c oxidase. The Biospherix 
box maintained the cells at 1% oxygen concentration and 5% CO2 concentration and 37ºC for 3 
hours after the cells reached 1% oxygen levels, approximately 15 minutes after closing the 
Biospherix box door.  
 
Protein Extraction and Quantification 
Thermo-scientific Mammalian Protein Extraction Reagent, M-PER (78501) was 
added to pelleted cells, or directly to cells on the plates, with 1% mammalian protease inhibitor 
cocktail (Sigma, P8340), and allowed to incubate for 5 minutes to lyse open the cells. Samples 
were collected and centrifuged at 14,000 g’s for a minimum of 15 minutes at 4ºC to pellet down 
the membrane and DNA. The protein in the supernatant was transferred to a separate 
microcentrifuge tube and stored separately -20ºC. Proteins were quantified using a 660 nm 
Protein Assay Reagent (ThermoScientific, 22660, similar to a Bradford reagent). 50 µL of 
diluted protein samples were incubated for 10 minutes in 1.5 mL of 660 nm Protein Assay 
Reagent and the absorbancies were measured at 660 nm. The concentration of protein samples 
were calculated from a BSA standard.  
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Treatment for positive and negative controls 
For a positive nitrated protein control, BSA was incubated in 100 mM potassium 
phosphate buffer, pH 7.0, 1 mM FeCl3, 1 mM EDTA, and 2 mM peroxynitrite for 30 minutes at 
room temperature on a rotisserie. The nitrated BSA was centrifuged for 30 minutes at 7,500 g’s 
and 4ºC and washed thrice through a Microsep Centrifugal Device (Pall Life Sciences 
ODO10C4),  with 50 mM potassium phosphate pH 7.0, 1 mM EGTA, centrifuging for 15 
minutes at 10,500 g and 4ºC.  
For nitrotyrosine reductions the proteins were submitted to SDS PAGE and 
transferred to PVDF membranes (See SDS PAGE and Western Blot for details). After transfer to 
PVDF membranes and before blocking, the blot was placed in 100 mM sodium dithionite and 
100 mM sodium borate, pH 9.0, and incubated in an air-tight container for 3 hours at room 
temperature. 
 
Protein precipitation and delipidation 
Proteins were precipitated with a methanol/chloroform solution. 600 µL of 
methanol was added to 150-300 µg of protein sample, followed by vigorous mixing and 150 µL 
of chloroform, again with vigorous mixing. 450 µL of distilled H2O was added to the sample and 
mixed, generating a cloudy precipitate containing the proteins. The samples were centrifuged for 
5 minutes at 12,000 g’s to pellet down the proteins. The supernatant was discarded while the 
protein pellet was dried by mildly heating on a heating block until nearly clear.  
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Polyacrylamide gel electrophoresis, SDS-PAGE 
Protein extracts were diluted in an appropriate amount of 2X Cracking Buffer [1 
mL 1 M NaPO4, 2 g SDS (Sigma L4390), 30.85 mg DDT (Sigma D9779), 4 mL 100% Glycerol,  
Bromophenol Blue (Sigma 29H3653), brought up to 20 mL in dH2O], and separated on a 4-20% 
Precast Polyacrylamide Gel, (PAGEr® Gold 58511). The gels were run in a 1X TGS Running 
Buffer consisting of 25mM Tris, 192mM Glycine and 0.1% SDS with 150 V until the dye front 
reached the bottom of the gel. The gels were either visualized by Blue Silver (0.12% Coomassie 
Blue, 10% Phosphoric Acid, 10% Ammonium Sulfate, 20% Methanol) or transferred to PVDF 
membranes for immunoblotting.  
 
Western Blot 
The proteins from the polyacrylamide gels were transferred to a PVDF membrane 
via semi-dry transfer using 1X TBS Semi-Dry Transfer Buffer (48mM Tris, 39mM Glycine, 
0.037%SDS). The transfer ran at constant mA, with 0.8 mA/cm2 of surface area, for 1.5 hours. 
The blots were then removed and washed with distilled H2O, followed by 10 minutes of PBS-T 
[80mM Na2HPO4, 20mM NaH2PO4, 1.0 M NaCl, pH 7.5, and 0.1% Tween (OmniPur 
Polyoxyethylene Sorbitan monolaurate, 9480)]. The blots were then blocked immediately, or 
dried before storing at 4ºC until blocking with Starting Block (ThermoScientific 37538) + 0.1% 
Tween, (Pierce, Surfact Amps 20, 28320). The gels were removed from the semi-dry transfer and 
stained with Blue Silver (0.12% Coomassie Blue, 10% Phosphoric Acid, 10% Ammonium 
Sulfate, and 20% Methanol) to visualize transfer efficiency. To detect protein nitration, the blots 
were washed with PBS-T twice for 15 seconds and then three times for 15 minutes. Afterwards, 
the blots were incubated in 1º anti-nitrotyrosine antibody. Both Calbiochem (487924) and 
C a r l s o n  | 17 
Cayman Chemicals (10006778) polyclonal anti-nitrotyrosine raised in rabbit were used at a final 
concentration of 0.2 µg/mL. Control blots used 0.1 µg/mL anti-α-Tubulin in mouse 
(ThermoScientific, 31430). After washing again in PBS-T twice for 15 seconds and then three 
times for 15 minutes, the blots were placed in 2º Antibody, a 1:50,000 dilution of anti-rabbit in 
goat, HPR conjugated (Rockland p/n611-1323), or a 1:20,000 dilution of anti-mouse HPR 
conjugated antibody (NeoMarkers, MS-581 – PABX). The blots were incubated in Western 
Lightning (Perkin Elmer NEL102001EA), for 30 seconds, and exposed to Optimum Brand X-
Ray film (XR-0810-100) and developed. 
 
Immunoprecipitation 
Proteins were immunoprecipitated using 25 µg of Cayman Chemicals Polyclonal 
Anti-nitrotyrosine antibody (10006778), covalently cross linked to Protein A/G on agarose beads 
as detailed by Pierce Crosslink ImmunoPrecipitation Kit (26147). The antibody was incubated 
with the Protein A/G-Agarose bead complexes for 2 hours on a rotisserie at room temperature, 
and cross linked with 0.45 mM disuccinimidyl suberate, DSS, for 60 minutes on a rotisserie at 
room temperature. Nitrotyrosine containing proteins were immunoprecipitated out of the cell 
lysate by incubating 1000 µg of protein from a maxishift aerobic, hypoxic and hypoxic + 1 mM 
PTIO (Sigma) cell samples with the prepared antibody-protein A/G complexes overnight on a 
rotisserie at 4ºC. The non-nitrated proteins were removed by washing thrice with 200 µL of TBS, 
and once with 100 µL of conditioning buffer as provided by the kit. The nitrated proteins were 
eluted with 10µL of elution buffer, pH 2.8, followed by 50 µL after letting the complexes sit for 
5 minutes. The antibody-protein A/G complexes were stored in 200 µL of coupling buffer. The 
nitrated peptides were quantified by ThermoScientific’s 660nm Protein Quantification. 
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High Pressure Liquid Chromatography, HPLC 
Instruments used included the Waters 600S Controller, Waters 626 Pump, Waters 
996 Photodiode Array Detector, Waters In-Line Degasser, and a Waters Temperature Control 
Module.  
C18 Reverse Phase Chromatography – Standards were run on the reverse phase 
C18 column on, (XBridge, 3.5µm 4.6x150mm) inside a Column Heater Module kept at 30.0ºC, 
preceded by an XBridge C18 3.5µm Pre-column. 1.25x10-4 M L-tyrosine and 3-L- nitrotyrosine 
(Sigma, T-3754 and Sigma N7389 respectively) standards in dH2O + 0.1% trifluoroacetic acid, 
TFA, were separated using a constant gradient of 2-40% acetonitrile + 0.1% TFA, in H2O + 
0.1% TFA, from 0 to 20 minutes followed by 2% acetonitrile + 0.1% TFA in H2O + 0.1% TFA 
for 10 minutes at a flow rate of 1 mL/min and injection volume of 20 µL. Absorbancies were 
measured over a spectrum from 210 nm to 400 nm (every 1.2 nm, with a sample rate of 1 
second). The C18 column was kept in 100% acetonitrile when not in use. 
Gel Filtration Chromatography – Protein samples that had been precipitated were 
separated on two Zorbax Gel Filtration columns, GF-450 (9.4x250mm, 6µm) and GF-250 
(9.4x250mm, 4µm) preceded by a Zorbax Reliance Guard Column (4.6x12.5mm, 5µm), run in 
series inside a Column Heater Module kept at 30.0ºC. 500µg of precipitated protein samples 
were resuspended in 100 µL HPLC Running Buffer, 6 M Guanidinium Hydrochloride, 0.5 M 
KH2PO4 pH 2.0 filtered through a 0.22 µM Millipore filter. Samples were then split in half, and 
an additional 35 µL of Running Buffer was added to the samples analyzed for nitration. 35 µL of 
10 mM dinitrophenylhydrazine, DNPH, in Running Buffer was added to the other half of the 
protein sample to measure protein carbonylation (final concentration of DNPH: 4.12 mM). The 
load for the column was 20 µL, and the sample was run through the column with a constant flow 
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rate of 1 mL/min in Running Buffer and absorbancies were measured at 280 nm for protein 
content, 357 nm for nitrotyrosine content, and 366 nm for carbonylation content. Columns were 
kept in dH20 + 0.1% TFA when not in use.  
Analysis of HPLC results – Relative protein tyrosine nitration was calculated by 
integrating the peaks in absorbance at 357 nm and dividing this value by the integration of peaks 
in absorbance at 280 nm. Carbonyl content was calculated as described previously by Dirmeier 
et al., where the carbonyl content of the untreated, (-DNPH) was subtracted from the carbonyl 
content of the treated (+DNPH) sample45. Using a molar extinction coefficient of 22,000 M-1 for 
hydrazone and estimated average molar extinction coefficient of 50,000 M-1 for all proteins, the 
carbonyl content was calculated as follows: 
Carbonyl Content (–DNPH) = 50,000 M-1 x A366 / (22,000 M-1 x A280) 
Carbonyl Content (+DNPH) = 50,000 M-1 x A366 / {22,000 M-1 x [A280 – (0.43 x A366)]} 
Actual Carbonyl Content = Carbonyl Content (+DNPH) – Carbonyl Content (-DNPH) 
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Figure 2 Specificity of anti-nitrotyrosine. 5 µg of BSA 
was nitrated by incubation with 2 mM peroxynitrite, and 
run next to 5 µg of untreated BSA, followed by 
treatment with 100 mM of sodium dithionite and 100 
mM of sodium borate for three hours for both nitrated 
BSA and BSA (A.). Aerobic, 90 min and 180 min 
protein samples following a minishift were precipitated 
for protein, run on SDS-PAGE transferred to PVDF for 
Western blotting (B.) with anti-nitrotyrosine (0.2 µg/mL 
Cayman Chemicals) and anti-rabbit (1:50,000, 
Rockland). The same samples were also incubated in 
100 mM sodium dithionite and 100 mM sodium borate 
to reduce the nitrotyrosines to aminotyrosines.  
Results 
 
Immunochemical Approaches to Nitrotyrosine detection 
It has been previously demonstrated that tyrosine nitration increases following a 
shift to hypoxia in yeast cells8. I wished to evaluate whether a similar increase in tyrosine 
nitration is observed in mammalian HEK293 cells shifted to hypoxic conditions. Several 
commercial antibodies are available; however these antibodies have also been reported to have 
various amounts of non-specific signal. To assess the specificity of the anti-nitrotyrosine 
antibodies, I evaluated the specificity of several anti-nitrotyrosine antibodies. Native BSA and 
nitrated BSA (prepared as described in Materials and Methods), were run on SDS-PAGE and 
blotted for nitration. The Cayman anti-nitrotyrosine antibody (Figure 2A) demonstrated a 
positive signal in the nitrated BSA and no signal with the native BSA. Additionally, the signal 
observed in the positive control was prevented when the nitrotyrosine was reduced to 
aminotyrosine by incubation of the blot in 100 mM sodium dithionite and 100 mM sodium 
borate, further confirming the specificity of the antibody.  
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The Cayman anti-nitrotyrosine antibody was then used to evaluate nitration levels 
in whole cell lysates following a minishift (as described in Materials and Methods). As shown in 
Figure 1B, 50 µg of protein isolated from aerobic, 90 min anoxic, and 180 min anoxic samples 
following a minishift were run on SDS-PAGE and blotted for tyrosine nitration. At 18 kDa, there 
exists a transient increase in signal from the aerobic to 90 min anoxic sample, which decreases 
again at 180 minutes anoxia. This band is representative of earlier work in the lab, where low 
weight protein showed transient increase in nitration (unpublished data, Ball). However, these 
blots proved difficult to reproduce. The vast majority of nitration results using this and other 
anti-nitrotyrosine antibodies produced high levels of background noise that made Western blots 
more difficult to analyze (data not shown).  
 
To determine whether protein load and specificity played a role in the 
inconsistency in nitrotyrosine blots, the detection limit of the nitrotyrosine antibody was 
assessed. Decreasing loads of nitrated BSA were run on SDS-PAGE and blotted for nitrotyrosine 
content. Figure 3 demonstrates that the antibody produced a clear signal using 1.0 µg of nitrated 
BSA, but could barely detect 0.l µg of nitrated BSA; 0.05 µg and 0.01 µg nitrated BSA signals 
were undetectable. Since a distinct band needs to be seen above background noise, this 
experiment suggests that anti-nitrotyrosine antibody detection limit lies in the range of 1.0 µg for 
a single, strongly nitrated protein. In complex protein samples like I am using, there are more 
than 200 proteins visible on a one dimensional gel, and only a fraction of any one protein may be 
Figure 3 Detection limit of nitrated BSA. BSA was nitrated 
with 2 mM of peroxynitrite for 30 minutes and 5.0, 1.0, 0.1, 
0.05, and 0.01 µg of nitrated BSA was run on SDS-PAGE 
followed by Western blotting with anti-nitrotyrosine (0.2 
µg/mL, Cayman Chemicals) and anti-rabbit (1:50,000, 
Rockland). The blots are representative of two separate 
experiments.  
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nitrated under our experimental conditions, suggesting that the protein-gel load needed for 
quantification using this anti-nitrotyrosine antibody would be above 100 µg. Unfortunately, more 
than a 60 µg protein-gel load caused excessive band distortion sot that the distinction between 
proteins was not possible (gel stain & blot data not shown).  
 
Rarity of Protein Tyrosine Nitration 
Due to the difficulty with western 
blots in visualizing changes in nitrotyrosine levels 
upon shifts to hypoxia, nitrated proteins were 
enriched by immunoprecipitation before running on 
SDS-PAGE. The Cayman Chemical anti-
nitrotyrosine antibody was covalently cross linked 
to Protein A/G complexed with agarose beads using 
DSS. Protein samples from aerobic, hypoxic and 
hypoxic + 1 mM PTIO samples following a 
maxishift were incubated with the anti-nitrotyrosine 
antibody, allowing non-nitrated proteins to wash 
through the column, while the anti-nitrotyrosine 
antibody held nitrated proteins bound to the column. 
The eluents were quantified for protein content using 
Pierce’s 660 reagent. As seen in Figure 4A, ~1.5% of 
the total protein eluted as containing nitrotyrosines. This 
is much higher than reported by other sources, which 
Figure 4 Immunoprecipitation of nitrated 
proteins. 1000 µg of aerobic, hypoxic, and 
hypoxic + 1 mM PTIO protein samples 
following a maxishift to 1% oxygen for three 
hours were immunoprecipitated using Pierce’s 
Crosslink Immunoprecipitation Kit (26147) 
using 25 µg of anti-nitrotyrosine (Cayman 
Chemicals) cross linked by incubating in DSS 
for 60 min. Eluted proteins were quantified 
with Pierce’s 660 nm reagent using a BSA 
standard (A.). The fold increase from the 
aerobic samples or relative nitrotyrosine 
content is depicted in (B.)  
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suggest that only 0.016% of proteins should be nitrated46,47. This finding that more than 1% of 
the proteins immunoprecipitated with the anti-nitrotyrosine antibody may be attributed to non-
specific binding to the antibody, or may represent error in protein quantification. Nevertheless, 
when the protein samples are normalized to the aerobic sample, there exists an increase in 
nitrated peptides following a hypoxic shift (Figure 4B). While the relative amounts of non-
nitrated protein between the aerobic, hypoxic and hypoxic + 1 mM PTIO remains relatively the 
same, the amount of nitrated proteins increase under hypoxia and is brought down slightly by 
PTIO, a NO. scavenger. The discrepancies between the fractions of proteins that are nitrated 
found here and what is cited in the literature, along with a very small recovery yield of nitrated 
protein directed the study towards assessing nitrotyrosine content without using anti-
nitrotyrosine antibodies. 
 
Validation of Relative Nitration using HPLC 
High pressure liquid chromatography, HPLC, coupled to a photodiode array 
(PDA) detector has previously been shown to be an efficient method of quantifying nitration in 
complex biological samples42,48. To validate the use of HPLC-PDA to quantify nitration, 
standards of tyrosine and nitrotyrosine amino acids were run on a reverse phase C18 column and 
the absorbance was measured. As shown in Figure 5, tyrosine and nitrotyrosine amino acids have 
distinct absorbance spectra. Tyrosine has a single absorbance peak in the 280 nm range, and 
nitrotyrosine contains two peaks, one in the 280 nm range, and a broad peak in the 360 nm range. 
This spectrum has previously been observed by Crow and Beckman, who used 357 nm to 
monitor nitrotyrosine, as no other naturally occurring amino acids absorb in this region48. 
Therefore, the 280 nm and 357 nm wavelengths can be used to monitor tyrosine and 
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nitrotyrosine elution. As shown in Figure 6A, the 280 nm absorbance shows the elution of both 
the tyrosine amino acids and the nitrotyrosine amino acids, while the 357 nm absorbance shows 
only the nitrotyrosine species (B.). As expected, the tyrosine amino acid elutes first, followed by 
the nitrotyrosine amino acid which is retained longer on the C18 column due to the increased 
hydrophobicity of nitrotyrosine under the acidic conditions of the running buffer49. Together, 
Figure 5 and Figure 6 demonstrate the specificity of absorbance at 357 nm to nitrotyrosine when 
comparing nitrotyrosine and tyrosine amino acids, validating the use of 357 nm to monitor 
nitrotyrosine.  
 
 
 
Figure 6 Chromatogram of tyrosine and nitro-
tyrosine. 1.25x10-4 M (--) tyrosine and (--) nitro-
tyrosine in dH2O + 0.1% TFA was run on a 
reverse phase HPLC using a C18 column kept at 
30ºC with a gradient of 2-40% acetonitrile + 
0.1% TFA and flow rate of 1 mL/min. Eluents 
were measured for absorbance at 280 nm (A.) 
and 357 nm (B.).  
Figure 5 Spectra of tyrosine and nitrotyrosine. Samples 
containing 1. 25x10-5 M nitrotyrosine (--) and 1.125x10-4 M 
tyrosine (--) were run through reverse phase HPLC on a C18 
column kept at 30ºC with a gradient of 2-40% acetonitrile + 
0.1% TFA and a flow rate of 1 mL/min. The spectra are 
taken at the elution time of the tyrosine peak and the 
nitrotyrosine peak at 7.14 min and 10.23 minutes 
respectively.  
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To establish a quantitative relationship between nitrotyrosine absorbance at 357 
nm and the total tyrosines observed at 280 nm, a concentration curve was made. Figure 7A 
depicts the absorbance at 280 nm when fraction of nitrotyrosine content increases to 100%. Even 
though the total amount of tyrosines remains constant, it is clear there is a linear increase in 280 
nm absorbance as the percent of nitrotyrosine increases. Figure 7B shows the same linear trend 
when measuring the absorbance at 357 nm. 
However, when the ratio of 280 nm to 357 nm 
is taken, a linear fit can only describe the data 
points up to 10% nitrotyrosine (Figure 7C). A 
linear trend has also been previously reported 
up to 1% nitrotyrosine content of simple protein 
samples50. Due to the observation that less than 
1% of tyrosines are biologically nitrated, and a 
linear fit between 0% and 10% nitrotyrosine, 
the ratio of absorbance in 357 nm over 280 nm 
may be used to determine relative protein 
nitration in complex biological samples. More 
interestingly past 10% nitrotyrosine, the data 
points follow a rectangular hyperbolic curve with 
an R2 of 0.99 (C), which may be used in future 
studies to more accurately quantitate protein 
nitration; however additional results would be 
necessary to confirm this observation. 
Figure 7 Analysis of tyrosine and nitrotyrosine 
absorption at 357 nm and 280 nm. Fractions of 
nitrotyrosine and tyrosine to a final concentration of 
1.25x10-4 M, were run on reverse phase HPLC 
using a C18 column kept at 30ºC and eluted with a 
gradient of 2-40% acetonitrile + 0.1% TFA and a 
flow rate of 1 mL/min. The total absorbance at 280 
nm (A.), 357 nm (B.), and 280/357 nm (C.) were 
monitored. A linear trend line up to 0.1 
nitrotyrosine content is displayed (---), as well as a 
rectangular hyperbolic fit (- - -) , with the form 
f(x)=ax/(b+x)+cx/(d+x)+ex, and an R2 of 0.99.  
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From the data shown in Figure 5 and 7, the extinction coefficient for both tyrosine 
and nitrotyrosine can be determined using Beer’s law. Beer’s law states A=ɛcl, where A is 
absorbance, ɛ is the extinction coefficient at that absorbance, c is the concentration of the species 
and l is the path length of the sample. In this system, the path length is 1cm and the pure tyrosine 
and nitrotyrosine samples are 1.25x10-4 M. For nitrotyrosine, the absorbance at 280 nm is 
0.185190, resulting in an extinction coefficient of 1481 M-1cm-1.  The ɛ280 of tyrosine is 253 M-
1cm-1, with an absorbance of 0.031721. The ~5.8 fold increase in the ɛ280 of nitrotyrosine over 
tyrosine has previously been observed using purified protein samples48. The ɛ357 for nitrotyrosine 
was found to be 5531 M-1cm-1. In future studies, these values may also be incorporated to 
quantify the nitrated tyrosine content in biological samples rather than determining the relative 
increase in nitration.  
 
Nitration and Carbonylation increase following Hypoxia 
While these calculations utilized a C18 column, this type of column can only 
process digested peptides, rather than complex protein samples. This lab has previously used a 
gel filtration column to analyze increases in protein carbonylation in yeast45. I modeled the 
nitration quantification analysis after this protocol, quantifying carbonylation in parallel as a 
control. In order to determine relative nitration following hypoxia, I used a gel filtration column 
to separate proteins based on apparent molecular weight. A ladder was first run on the gel 
filtration column containing BSA (1), cytochrome c (2), and nitrotyrosine (3), as shown in Figure 
8A, where absorbance was monitored at 357 nm (--) and 280 nm (--). Cytochrome c (2) has a 
large absorbance at 357 nm resulting from peroxynitrite mediated tyrosine nitration that has been 
previously reported for purified cytochrome c51. When hypoxic samples are spiked with trace 
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amounts of the ladder (Figure 8B), there exists a 280 nm peak that belongs to the hypoxic protein 
sample outside the scope of the ladder (4), at a smaller molecular weight than the nitrotyrosine 
amino acid. The protein ladder provided the means of determining the range analysis and where 
to integrate the 280 nm and 357 nm peaks as represented by the brackets ([ ]). Because protein 
tyrosine nitration could not occur on anything smaller than a free tyrosine amino acid, the peak 
observed at 280 nm (4) outside the brackets was not included in the analysis.  
 
In order to determine an increase in both nitration and carbonylation following a 
hypoxic shift, protein samples were run on a gel filtration column and relative 
nitration/carbonylation content was determined as described in Materials and Methods. Figure 9 
demonstrates that after HEK293 cells shifted to 1% hypoxia for three hours, exhibit a 3-fold 
increase in nitration, and a 2-fold increase in carbonylation, representative of three distinct 
experiments. An increase in protein nitration and carbonylation in these mammalian cells 
following hypoxia confirms earlier observations in yeast cells8,32,45. Upon addition of a NO. 
Figure 8 Gel filtration protein ladder and spiked 
sample. A ladder consisting of 1 mg/mL BSA (1), 0.5 
mg/mL cytochrome c (2), and 0.5 mg/mL nitrotyrosine 
(3) in 6 M guanidinium hydrochloride, was run on a gel 
filtration column through HPLC at a flow rate of 1 
mL/min and 30ºC (A.) and monitored at 280 nm (--)and 
357 nm (--). A mixture of the ladder and 11.75 µg of  
protein in 6 M guanidinium hydrochloride following a 
hypoxic maxishift to 1% oxygen for three hours was 
also run on the gel filtration HPLC (B.). Absorbance 
was monitored at 280 nm (--), and 357 nm (--). The 
brackets, [ ] indicate the boundary of analysis.  
C a r l s o n  | 28 
scavenger, PTIO, immediately prior to the hypoxic shift cause the nitration levels to fall to 1.5-
fold of the aerobic nitration levels, while carbonylation levels drop to 1.25 that of aerobic levels, 
representative of duplicate experiments. Preliminary data of the addition of a cytochrome c 
oxidase inhibitor, azide, suggests that cytochrome c oxidase produces the nitric oxide necessary 
for the increase in protein nitration and carbonylation following hypoxia. Carbonylation levels 
following a hypoxic shift in the presence of azide are equal to that of the hypoxia + PTIO levels, 
indicating that NO. produced by cytochrome c oxidase participates in the formation of 
carbonylation observed under hypoxia. With respect to nitration, the addition of azide brings 
down the relative nitration levels below that of the aerobic sample. Together, these data suggest 
that cytochrome c oxidase produces NO. under hypoxic conditions, and this NO. participates in 
both hypoxic protein carbonylation and nitration.  
Figure 9 Nitric oxide – dependent increase in 
nitration and carbonylation following a hypoxia. 
Protein samples from aerobic, hypoxic, hypoxic + 1 
mM PTIO and hypoxic + 5 mM azide following a 
maxishift to 1% oxygen for three hours were 
resuspended in 6 M guanidinium hydrochloride as 
described in Materials and Methods. Protein 
samples analyzed for carbonylation were
derivitized with 4.12 mM DNPH (final 
concentration) before running through the gel 
filtration HPLC at a flow rate of 1 mL/min and 
30ºC. Samples were monitored for absorption at 
280 nm, 357 nm and 366 nm. The relative nitration 
was calculated by taking the total absorption at 357 
nm over the total absorption at 280 nm, followed by 
normalization to the aerobic sample. The carbonyl 
content was calculated as described previously and 
normalized to the aerobic sample (45). 
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Discussion 
 
Peroxynitrite and Tyrosine Nitration 
Peroxynitrite, ONOO-, forms from the rapid reaction between superoxide, O2. and 
nitric oxide, NO.. Due to the nature of these reactants, the products of ONOO- mediated 
modifications such as nitration and carbonylation are viewed as markers of oxidative stress. 
While general oxidative damage by ONOO- may occur faster than specific protein tyrosine 
nitration, physiological conditions have been shown to modify ONOO- reactivity in favor of 
tyrosine nitration, such as the addition of carbon dioxide or the presence of transition metals, 
abundant in physiological samples49,52. ONOO- mediated protein tyrosine nitration proceeds via 
one of two mechanisms. In the presence of transition metals, ONOO- forms a metal-peroxynitrite 
complex that adds the electrophilic NO2, to the 3-position of the aromatic ring in tyrosine46. 
However, it is the second mechanism that occurs via a free radical pathway that is thought to 
play a role in cellular processes. The combination of ONOO- with carbon dioxide forms 
ONOOCO2- which rapidly decomposes to two free radical species, .CO3 and .NO249. The 
carbonate free radical reacts with tyrosine to form bicarbonate and the tyrosyl radical, which then 
interacts with .NO2, generating the final product, 3-nitrotyrosine53.  
Because mitochondria generate both O2.- and NO., mitochondrial proteins appear 
highly enriched in nitrated tyrosines49. Furthermore, many nitrated proteins in the mitochondria 
are those involved with citric acid cycle and fatty acid metabolism suggesting an alteration of 
these pathways under hypoxia due to the addition of the nitro group to the tyrosines54. The 
mitochondrial electron transport chain may play a role in the increased protein tyrosine nitration, 
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as the mitochondrial proteins are in the immediate vicinity of the electron chain, and are thus 
susceptible to ONOO- mediated modification.  
 
Selectivity of Tyrosine nitration 
Protein tyrosine nitration has been demonstrated to be selective in which tyrosines 
are nitrated within a protein. For physiological nitration, not only must the tyrosine be solvent 
accessible, but additional factors also affect tyrosine nitration. ONOO- catalyzes the site selective 
nitration of RNase A, lysozyme and human serum albumin, where only a few of the total 
tyrosines in the protein are nitrated55,56. In addition to the inequality of tyrosine residues within a 
protein, not all proteins are made equal in susceptibility to tyrosine nitration, where some 
proteins are highly nitrated while others are minimally nitrated52,55,57. Not all tyrosine residues 
are available for nitration due to accessibility, or charge interactions in surrounding amino acids, 
where negatively charged residues such as glutamate, increase a tyrosine’s likelihood to become 
nitrated55. My results have confirmed the rarity of nitrotyrosine formation through 
immunoprecipitation as seen in Figure 4, where only 1.5% of the proteins eluted as nitrated. 
However, due to the selectivity of nitration, immunochemical approaches have revealed large 
inconsistencies between results, and consequentially the vast majority of nitrotyrosine western 
blots could not replicate one another. 
 
Protein Nitration following Hypoxia 
The results from HPLC analysis demonstrate an increase in nitration following a 
hypoxic shift at 1% oxygen for three hours. While these results remain preliminary, the increase 
in nitration that is diminished by the addition of PTIO and azide confirms an increase in 
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cytochrome c oxidase produced NO. following hypoxia in mammalian cells. Nitrotyrosine 
formation was monitored by absorbance at 357 nm, as no other naturally occurring amino acids 
absorb at 357 nm. However, there are other species that absorb in this wavelength range which 
may affect the results. Metal porphyrins like cytochromes, when oxidized, absorb in the 357 nm 
region58. Yet, under oxidizing conditions, such as those experienced during hypoxia, the cell 
maintains metal-cytochrome complexes in a reduced state, such that these species do not 
contribute to the absorbance at 357 nm. Additionally, the increase in absorbance at 357 nm 
following hypoxia, corresponds with the increase in nitration observed by immunoprecipitating 
for nitrated proteins, suggesting that 357 nm monitors the specific absorbance of nitrotyrosines.  
The increase in nitration following hypoxia in mammalian cells reflects an earlier 
study in yeast, showing a general increase in tyrosine nitration8. My study suggests that 
cytochrome c oxidase generates the NO. required for hypoxic peroxynitrite mediated protein 
tyrosine nitration. This finding suggests that the nitric oxide generated by cytochrome c oxidase 
plays a role in nitrative stress and potentially in hypoxic cell signaling, rather than the nitric 
oxide produced by nitric oxide synthase under hypoxic conditions. Under hypoxia, the NMDA 
(N-methyl-D-aspartate) receptor in the brain was found to be selectively nitrated in a nitric oxide 
dependent manner, allowing a higher influx of Ca2+ into the cell when nitrated59. Many nitrated 
proteins acquire new functions or lose activity, suggesting that protein tyrosine nitration may 
play a relevant role in hypoxic cell signaling. For example, nitrated ATPases have been shown to 
decrease ATPase activity in the rat liver mitochondria, and many nitrated peptides show an 
increase in susceptibility to protein degradation49,55. The difference in physiochemical properties 
of nitrotyrosine versus tyrosine may explain the impact of tyrosine nitration on protein function. 
Nitrotyrosine has a lower hydroxyl pKa than that of tyrosine, leaving the nitrotyrosine more 
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negatively charged than the slightly hydrophobic tyrosine residue49. The nitro group also attaches 
an additional steric hindrance to the amino acid that may result in changed protein conformations 
or affect protein binding abilities49. In diabetic rat retinopathy, nitrated tyrosines lose the ability 
to become phosphorylated, which may contribute to the physiological role of diabetic 
retinopathy60. Tyrosine nitration on targeted residues for phosphorylation or other post-
translational modifications implicate potential consequences for signal transduction pathways, as 
tyrosine phosphorylation plays a major role in cellular signaling.  
In addition to the specificity and altered function of proteins containing nitrated 
tyrosines, the reversibility of the modification must be demonstrated in order for protein nitration 
to function as part of a signaling pathway. Denitration is a process that was originally thought to 
be impossible as nitrotyrosines are chemically very stable and cannot be further modified by 
oxidative agents42. More recently, a denitration processes has been shown in mitochondria, 
operating in a non-proteosomal dependent manner upon reoxidation of the cell54. With 
demonstrated selectivity, change in function, and now a process of denitration, protein tyrosine 
nitration may operate as part of hypoxic cellular signaling.  
 
Carbonylation following Hypoxia 
Protein carbonylation occurs on arginine, threonine, proline and lysine residues as 
they are oxidized by reagents such as OH.-, O2.-, H2O2, and ONOO- 44,61. In addition to being 
nitrated, a number of citric acid cycle proteins are also carbonylated under oxidative stress, 
resulting in loss of function, with the oxidative species required for such oxidation coming from 
the mitochondria44,62. The carbonylation of these proteins complement HIF-α’s role in up-
regulating glycolytic enzymes. I find that both carbonyl and nitrotyrosine content in proteins 
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increase during hypoxia, as many nitration and carbonylation studies observe concurrent 
increases in these protein modifications61. Like tyrosine nitration, protein carbonylation may also 
function as part of a signaling pathway.  
While ROS mediated protein carbonylation has been known, the NO. dependence 
of protein carbonylation following hypoxia is relatively novel. Here I demonstrate an increase in 
protein carbonylation following a hypoxic shift as seen in Figure 9. Like the nitrated proteins, the 
carbonylation was also nitric oxide dependent, with the addition of PTIO reducing the carbonyl 
content back to near-aerobic levels. The addition of azide instead of PTIO to hypoxic cells 
resulted in the same reduction of carbonyl content that was established by the addition of PTIO. 
These results suggest that peroxynitrite also mediates carbonylation following the onset of 
hypoxia, and that the nitric oxide derived from cytochrome c oxidase contributes to the increase 
in hypoxic protein carbonylation.  
Previously, a transient increase in protein carbonylation following hypoxia was 
demonstrated, although it is unknown whether or not the decarbonylation process is proteolytic32. 
The reversibility of protein carbonylation must be demonstrated in order for the process to 
participate in a signaling pathway. More recently, the reversibility of protein carbonylation was 
observed, and decarbonylation implicated a proteosomal independent pathway, with thioredoxin 
proposed in the decarbonylation mechanism63. Protein carbonylation has been shown as 
reversible, specific and altering protein function, which suggests post-translational protein 
modification by carbonylation may also be involved in hypoxic signaling pathways.  
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Nitration and Carbonylation and Hypoxic Cell Signaling 
Both nitration and carbonylation meet the criteria to participate in cellular 
signaling pathways by being specific, conferring altered functions on the proteins, and having 
shown reversibility in the cell. While this study has not yet identified the nitrated and 
carbonylated proteins following hypoxia, these proteins may act directly or indirectly to induce 
HIF-α stabilization. An example of a modification directly stabilizing HIF-α is the nitration of 
HIF-α itself. On HIF-1α, there is a tyrosine directly next to Pro564 which is the target of 
hydroxylation under aerobic conditions. The nitration of Tyr565 may inhibit the hydroxylation of 
Pro564, and consequently result in the hypoxic stabilization of HIF-1α. It has been previously 
observed that the nitration of one tyrosine residue affects the phosphorylation of another 4 amino 
acids away64. This suggests that a nitrotyrosine adjacent to the proline may inhibit the proline’s 
subsequent hydroxylation. Alternatively, a protein that interacts with HIF-α may be nitrated or 
carbonylated, inducing the stabilization of HIF-α.  
 
Alzheimer’s, Protein Nitration, Carbonylation and Hypoxia 
While post-translational modifications have not yet been confirmed as a 
mechanism for the hypoxic stabilization of HIF-α, oxidative stress induced protein modification 
has been correlated with mechanisms of aging. For example, aged rats have increased 
nitrotyrosines in ATPases, and general increases in nitration have been observed in patients with 
mild cognitive impairment, where nitration is proposed as the mechanism of some Alzheimer’s 
disease progression34,57. In addition to nitration, protein carbonylation has also been observed to 
be increased in patients with Alzheimer’s disease61. Specifically, the glycolytic enzymes α 
enolase and triosephosphate isomerase have increased nitration in brain tissue of Alzheimer’s 
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disease studies65. Interestingly, both Alzheimer’s disease and hypoxia display similar traits of 
increase in protein carbonylation and protein nitration. Furthermore, both hypoxia and sporadic 
Alzheimer’s disease observe increases in the transcriptional levels BACE1 (β site amyloid 
precursor protein cleaving enzyme), an enzyme regulated by the master hypoxic regulator, HIF, 
in a mitochondrially produced ROS dependent manner66-68. An aspect of Alzheimer’s disease is 
the aggregation of β-amyloid plaques, produced by the cleavage of amyloid precursor protein by 
BACE1. It appears that Alzheimer’s disease may be attributed in part to increased HIF-α 
stabilization under aerobic conditions in the brain, leading to increased levels of BACE169. By 
increasing the levels of BACE1, the levels of β-amyloid plaques are also increased, contributing 
to the Alzheimer’s disease state. It would be interesting to investigate whether the nitrated and 
carbonylated proteins increased in Alzheimer’s studies are similar to the proteins that show 
increased nitration and carbonylation under hypoxia. If so, these same modified proteins may 
function to stabilize HIF-α under normal oxygen concentrations, resulting in the up-regulation of 
BACE1 and the accumulation of β-amyloid plaques.  
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Conclusion 
 
Mitochondria are important to eucaryotic cells, not only for their role as energy producers 
and metabolic centers, but as signaling centers during times of stress. The presence of oxygen is 
essential, for without it, oxidative phosphorylation can no longer proceed. In a hypoxic state, the 
mitochondria produce reactive oxygen and nitrogen species such as superoxide and nitric oxide. 
Here, I observed increased tyrosine nitration and carbonylation, markers of oxidative stress, 
following hypoxic shifts that are dependent on nitric oxide produced by cytochrome c oxidase. 
Protein carbonylation and protein tyrosine nitration may be part of signaling mechanisms for the 
hypoxic stabilization of HIF-α as they have been demonstrated as specific, reversible, and alter 
the protein function. The signaling mechanism in which carbonylation and protein tyrosine 
nitration may participate to stabilize HIF-α following hypoxia arises from the production of 
reactive oxygen and nitrogen species by the mitochondria. The hypoxic stabilization of HIF-α 
results in regenerating the balance between the generation of oxidative species, ATP production 
and consumption. However, to determine the mechanism of this signaling pathway induced by 
protein nitration and/or carbonylation, the modified proteins must be identified. In future studies 
with the HPLC system, the fractions of protein containing nitrotyrosine, or carbonylated residues 
will be collected and subjected to separation on a C18 column for isolation and identification by 
MS/MS. Upon identification of the nitrated and carbonylated proteins, I would be able to 
construct a model for the mechanism of hypoxic HIF-α stabilization.   
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